Nexara Health — Health Canada Drug Establishment Licence #3-002896

Unregistered & Access Pathway Products

Compliant importation of unregistered drugs through Health Canada's Special Access Programme and other access pathways

When a patient needs a medication that is not marketed in Canada, access pathways such as Health Canada's Special Access Programme (SAP), the Emergency Drug Release (EDR) programme, and named-patient imports provide legal mechanisms to obtain these products. Navigating these pathways requires deep regulatory knowledge, established international sourcing networks, and meticulous documentation.

Nexara facilitates the importation and distribution of unregistered pharmaceutical products through all available Canadian access pathways. As a DEL-licensed establishment, we ensure that every importation complies with Health Canada requirements, including proper authorization, labelling, storage, and distribution documentation.

Our service covers the full spectrum of access pathway products — from rare disease orphan drugs to medications with limited Canadian availability, products in the regulatory approval pipeline, and treatments authorized in other jurisdictions but not yet registered in Canada.

What is included

Special Access Programme (SAP)

End-to-end support for SAP requests — from application assistance to product importation and delivery.

Emergency Drug Release

Expedited sourcing for emergency situations requiring immediate access to unregistered products.

Full Regulatory Compliance

Every importation authorized through proper Health Canada channels with complete documentation.

International Sourcing Network

Established relationships with verified suppliers in the US, EU, UK, and Asia-Pacific for global sourcing.

Expedited Timelines

Fast-track importation processes to minimize wait times for patients and healthcare providers.

Named-Patient Import

Individual patient-level importation with full traceability and healthcare provider coordination.

How it works

  1. Request & Assessment — We receive your access pathway request and assess the regulatory pathway and sourcing options.
  2. Authorization — Proper Health Canada authorization is obtained (SAP letter, EDR, or applicable pathway documentation).
  3. International Sourcing — Product is sourced from a verified international supplier with full quality documentation.
  4. Import & Delivery — Product is imported into Canada under proper licence, stored compliantly, and delivered to the requesting facility.

Request a quote

Nexara Health is a Health Canada–licensed pharmaceutical wholesaler (DEL #3-002896) based in Winnipeg, Manitoba, supplying hospitals, pharmacies, clinics, CROs, and trial sponsors across Canada. Send us the product, strength, presentation, and quantity for unregistered & access pathway products and we will come back with availability, source market, lead time, and landed cost — usually within 24 hours.

Request a sourcing quote or call +1 (431) 588-9055.

Related pages